vimarsana.com

Latest Breaking News On - Alpha tec systems inc - Page 3 : vimarsana.com

Microbix Announces Quality Products Distribution Agreement

Microbix Announces Quality Products Distribution Agreement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Microbix Announces Quality Products Distribution Agreement Appointment of SDT Molecular of Singapore

Microbix Reports Record Results for Q2 Fiscal 2021

14.05.2021 - Record Q2 Sales of $4.35 million, Record Net Earnings of $0.8 millionMISSISSAUGA, Ontario, May 13, 2021 (GLOBE NEWSWIRE) - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix), a life sciences innovator and exporter, reports results for its .

Microbix Announces $6 0 Million of Financings

Microbix Announces $6 0 Million of Financings
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Microbix & SpeeDx Form Exclusive Collaboration

Microbix & SpeeDx Form Exclusive Collaboration Search jobs MISSISSAUGA, CANADA and EVELEIGH, AUSTRALIA  April 26, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and SpeeDx Pty. Ltd. (SpeedDx), a developer of innovative molecular diagnostics solutions, are pleased to announce the formation of a collaboration under which Microbix will be exclusive developer of Quality Assessment Products (QAPs™) to facilitate the registration and commercialization of SpeeDx diagnostic assays. The collaboration will begin with support of SpeeDx’s diagnostic tests for infection with antimicrobial-resistant (AMR) strains of  Mycoplasma genitalium (AMR MGEN), a widespread sexually-transmitted infection and a test market expected to exceed US$ 1.0B globally by 2027.  AMR MGEN is known to have multiple mutations that render certain antibiotics ineffective against it. Accurate diagnosis of such drug-resistant infections requires c

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.